This is the authors' abstract. We don't add key points for this paper.
Seven families with six different SPG3A mutations were identified among 106 with autosomal dominant hereditary spastic paraplegia (HSP). Two mutations were novel (T162P, C375R). SPG3A was twice as frequent as SPG4 in patients with onset before age 10 years (31.8%). Later onset was not observed. The phenotype was pure HSP, but disease duration was longer than in non-SPG3A/SPG4 patients, leading ultimately to greater handicap.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Namekawa et al. (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: